Exploratory Signal Detection of Arrhythmia Reports for Empagliflozin, Sitagliptin, and Linagliptin in the Korea Adverse Event Reporting System
Studies have reported cardiovascular effects of Sodium-glucose cotransporter 2 (SGLT2) and dipeptidyl peptidase-4 (DPP-4) inhibitors.Although cardiovascular and renal benefits of SGLT2 inhibitors have been reported, their specific association with arrhythmias such as atrial fibrillation (AF), atrial flutter, and ventri...